Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 2001

View Archived Issues

Company Profile: Origenix Technologies

Pharmagene and Bayer form new alliance for validation of oncology targets

Vasogen receives approval in Canada to proceed with psoriasis trial

Arakis and KS Biomedix establish drug development alliance for arthritis

Collaboration for small-molecule drugs for urological disorders expanded by Abbott, Icagen

SynX and genOway form proteomics and genomics alliance

Chiron grants Japan Tobacco license to HCV drug target

Magainin reports highlights from 2000; name change announced

UroCor and Bioniche enter North American alliance for urology products

Novuspharma makes important progress in clinical programs during past year

GW-409544X reduces triglycerides and NEFAs following single doses to healthy volunteers

Blood-brain barrier penetration of GV-196771 following once-daily oral doses

Ertapenem pharmacokinetics in renal insufficiency discussed in Orlando

Clinical candidate for psoriasis Rx prepared in high yield at Roche

Succinyl hydroxamic acid identified at Pfizer as potent and selective MMP-3 inhibitor

NitroMed receives FDA letter regarding BiDil NDA

ASCPT news: effects of oral insulin product designed at Nobex in type 1 diabetes

Pharmacokinetics, pharmacodynamics of melagatran examined under different conditions

Update on Xolair BLA review by FDA

Roche seeks FDA approval for Xeloda/Taxotere combination for the treatment of breast cancer

Effects of age, gender and hepatic impairment on PK/PD of rosuvastatin

Neurotropic virus transport as a candidate target for antiviral therapy

Endothelin receptor antagonists claimed by BASF

Inhibitors of MTP and ApoB secretion designed to treat lipid and related disorders

Class of novel indole inhibitors of sPLA2 presented by Lilly

AstraZeneca presents new spirooxindole analgesics

New series of antiinflammatory compounds in development at Merckle

EO-1428, a new aminobenzophenone for acne and other skin disorders

Barcelona Science Park officially opens

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...